Literature DB >> 6997183

Collagen polymorphism in the lung. An immunochemical study of pulmonary fibrosis.

J A Madri, H Furthmayr.   

Abstract

The localization of type I, III, IV, and AB2 (V) collagens in normal and fibrotic human lungs was studied by indirect immunofluorescence techniques with affinity purified antibodies specific for these types of collagen. In the normal lung type I collagen appears to be localized to the interstitium of alveolar septa in irregular patterns. Type III appears to have a more prominent, irregular localization in septa and a perivascular localization. Types IV and V codistribute in linear patterns on alveolar and capillary basement membranes. Type V is also present in the interstitium. Dramatic changes in relative amounts and localization were noted in fibrotic lung samples by fluorescence microscopy. In fibrotic lung samples there is a marked increase in type I in thickened septae. Type III is markedly reduced and seen only in perivascular localization. Type V is markedly increased in the interstitium and located in areas of smooth muscle cell proliferation. No apparent change is noted in amount or localization of type IV collagen. These findings correlate well with biochemical data relating to the amounts of various collagens isolated by enzymatic extraction techniques. These results are discussed with respect to staging and evolution of the fibrotic process.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6997183     DOI: 10.1016/s0046-8177(80)80031-1

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  61 in total

1.  Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro.

Authors:  A Papapetropoulos; K M Desai; R D Rudic; B Mayer; R Zhang; M P Ruiz-Torres; G García-Cardeña; J A Madri; W C Sessa
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Immune responses to self-antigens in asthma patients: clinical and immunopathological implications.

Authors:  Michael Liu; Vijay Subramanian; Chandrika Christie; Mario Castro; Thallachallour Mohanakumar
Journal:  Hum Immunol       Date:  2012-02-17       Impact factor: 2.850

3.  Formation of extracellular matrix by cultured rat mesangial cells.

Authors:  E Ishimura; R B Sterzel; K Budde; M Kashgarian
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

4.  Modulation of actin mRNAs in cultured vascular cells by matrix components and TGF-beta 1.

Authors:  O Kocher; J A Madri
Journal:  In Vitro Cell Dev Biol       Date:  1989-05

5.  Alternative splicing of endothelial cell fibronectin mRNA in the IIICS region. Functional significance.

Authors:  O Kocher; S P Kennedy; J A Madri
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

6.  Intra-alveolar fibrosis of idiopathic bronchiolitis obliterans-organizing pneumonia. Cell-matrix patterns.

Authors:  S Peyrol; J F Cordier; J A Grimaud
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

Review 7.  Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.

Authors:  Justin C Hewlett; Jonathan A Kropski; Timothy S Blackwell
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

Review 8.  Extracellular superoxide dismutase in pulmonary fibrosis.

Authors:  Fei Gao; Vuokko L Kinnula; Marjukka Myllärniemi; Tim D Oury
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

9.  Distribution of collagen types I and III and basal lamina in human gastric carcinoma: an immunohistochemical and electron microscopic study.

Authors:  M Yamamoto; H Sumiyoshi; K Nakagami; K Taniyama; E Tahara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

10.  Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro.

Authors:  J R Merwin; W Newman; L D Beall; A Tucker; J Madri
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.